Abbvie (ABBV) PT Raised to $128 at Mizuho Securities
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $263.96 --0%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 13
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 13
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan raised the price target on Abbvie (NYSE: ABBV) to $128.00 (from $126.00) while maintaining a Buy rating.
You May Also Be Interested In
- AbbVie presents real-world Vraylar data at Psych Congress 2026
- AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
- Credo Tech (CRDO) PT Lowered to $245 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
